Updates in NMOSD management
Neuromyelitis Optica Spectrum Disorder: Updates on Diagnosis and Treatment ManagementПодробнее
Updates in the treatment of NMOSD: targeted agentsПодробнее
Neuromyelitis Optica Spectrum Disorder: Management Essentials for MS ClinicsПодробнее
Understanding and Managing Pain in TM, NMOSD and ADEMПодробнее
Dr. Anthony Traboulsee - Satralizumab: A New Era in NMOSD ManagementПодробнее
NMOSD Multidisciplinary Approach Webinar, 25 June 2021 - Dr. Suzan Ibrahim NooriПодробнее
Evolution of understanding and treatment in NMOSDПодробнее
Diagnostic criteria and treatment updates for NMOSDПодробнее
NMOSD: Disease Modifying Therapies [2024 Update]Подробнее
![NMOSD: Disease Modifying Therapies [2024 Update]](https://img.youtube.com/vi/pMLnLS0U7F8/0.jpg)
2021 RNDS | A Treatment Option for NMOSDПодробнее
Recent progress and future needs in NMOSD treatmentПодробнее
206. History, Diagnosis, and Management of NMOSDПодробнее
Latest developments in neuromyelitis optica spectrum disorderПодробнее
Early diagnosis and treatment of NMOSD: Practical insightsПодробнее
The interdisciplinary management of NMOSD to improve clinical outcomesПодробнее
SAkura: long-term safety and efficacy of satralizumab for NMOSDПодробнее
Updates on N-MOmentum: inebilizumab versus placebo in patients with NMOSDПодробнее
2022 RNDS | What are the long-term treatments for NMOSD and MOGAD?Подробнее
Dr. Anu Jacob l NMOSD Therapy UpdateПодробнее
2023 NMOSD Together | Live Q&A SessionПодробнее
